|
Market Closed -
Nasdaq
02:27:12 07/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.6574 USD | -3.32% |
|
-7.66% | -42.33% |
| 26/10 | Top Premarket Gainers | MT |
| 12/10 | Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use | MT |
Company Valuation: IRIDEX Corporation
Data adjusted to current consolidation scope
| Fiscal Period: January | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 101.9 | 32.94 | 45.17 | 29.45 | 20.11 | 11.94 | - | - |
| Change | - | -67.66% | 37.12% | -34.81% | -31.7% | -40.61% | - | - |
| Enterprise Value (EV) | 101.9 | 32.94 | 45.17 | 29.45 | 20.11 | 11.94 | 11.94 | 11.94 |
| Change | - | -67.66% | 37.12% | -34.81% | -31.7% | -40.61% | 0% | 0% |
| P/E | -18.9x | -4.38x | -4.71x | -3.28x | -4.5x | -5.67x | - | 9.71x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.1x | -0.2x | 0.39x | 0.1x | 0.1x | - | - |
| Capitalization / Revenue | 1.89x | 0.58x | 0.87x | - | 0.38x | 0.23x | 0.21x | 0.2x |
| EV / Revenue | 0x | 0x | 0x | - | 0x | 0.23x | 0.21x | 0.2x |
| EV / EBITDA | -0x | -0x | -0x | - | 0x | 9.51x | 3.64x | 2.57x |
| EV / EBIT | -0x | -0x | -0x | - | -0x | -8.36x | 27.1x | 6.53x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.34 | -0.47 | -0.59 | -0.54 | -0.26 | -0.12 | - | 0.07 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 53.9 | 56.97 | 51.87 | - | 52.68 | 52.52 | 55.98 | 60.01 |
| EBITDA 1 | -6.73 | -7.057 | -7.259 | - | 1.122 | 1.256 | 3.281 | 4.65 |
| EBIT 1 | -7.533 | -7.542 | -10.01 | - | -2.571 | -1.429 | 0.441 | 1.828 |
| Net income 1 | -5.225 | -7.547 | -9.57 | -8.91 | -4.437 | -2.086 | 0.001 | 1.466 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 6.4200 | 2.0601 | 2.7800 | 1.7700 | 1.1700 | 0.6800 | 0.6800 | 0.6800 |
| Nbr of stocks (in thousands) | 15,866 | 15,990 | 16,248 | 16,636 | 17,190 | 17,565 | - | - |
| Announcement Date | 10/03/22 | 09/03/23 | 26/03/24 | 27/03/25 | 26/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.67x | - | - | - | 1.19Cr | |
| 34.66x | 5.93x | 22.65x | 0.27% | 25TCr | |
| 53.97x | 13.11x | 28.13x | -.--% | 16TCr | |
| 35.98x | 6.85x | 21.44x | 0.64% | 16TCr | |
| 18.26x | 3.59x | 11.7x | -.--% | 6.47TCr | |
| 39.97x | 8.04x | 25.42x | -.--% | 5.8TCr | |
| 22.04x | 2.61x | 13.16x | 2.29% | 5.62TCr | |
| 47.48x | 11.69x | 25.77x | -.--% | 5.02TCr | |
| 33.47x | 6.63x | 22.53x | 0.6% | 4.84TCr | |
| 110.61x | 7.51x | 22.85x | -.--% | 4.45TCr | |
| Average | 39.08x | 7.33x | 21.52x | 0.42% | 8.95TCr | |
| Weighted average by Cap. | 41.20x | 7.60x | 22.40x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IRIX Stock
- Valuation IRIDEX Corporation
Select your edition
All financial news and data tailored to specific country editions
